Stuart Cable > Goodwin > Boston, United States > Lawyer Profile

Able to call upon a network of intellectual property, real estate and tax experts, Goodwin is best known for its strong track record in complex M&A involving life sciences, tech, and private equity players. The department is well positioned to handle public and private M&A, leveraged buyouts, and spin-offs, and is also skilled in shareholder activism defense and proxy contests. Based in Boston, Stuart Cable spearheads the global M&A practice. Cable is counsel of choice for a number of leading tech and life sciences clients, who retain him on a recurrent basis in transactional and corporate governance matters. On the West Coast, Alessandra Simons is a prominent M&A figure in San Francisco, while Andrew Weidhaas in Los Angeles focuses on private equity deals and emerging companies.

Goodwin’s life sciences team assist a diverse roster of pharmaceutical companies – both public and private – and life science venture capital firms. Mitchell Bloom and Kingsley Taft  jointly lead the team; Taft primarily advises life sciences companies throughout their life cycles on formation, venture financings, and IPOs, while Bloom is active in the biotechnology and medical IT spaces. Boston-based Robert Puopolo maintains a transactions focused practice, handling joint ventures and life sciences M&A. In San Francisco, Alexander Varond takes the lead on litigious matters concerning biosimilars and the Hatch-Waxman Act. Stuart Cable is particularly adept at advising on corporate governance and venture sourced investment, while Danielle Lauzon assists boards and management teams of therapeutics and bioscience companies. A large team including Philadelphia-based Rachael Bushey, who specializes in transactional and governance work in the pharma and biotech space, joined the firm from Troutman Pepper in January 2023. All named practitioners are based in Boston unless specified otherwise.